Ronny - Interview 42
Ronny was invited by his GP to be screened for prostate cancer as part of a trial. He discovered he had cancer. He was randomised to have radical surgery (rather than monitoring or radiotherapy) and is pleased with how it went.
Ronny is a retired painter and decorator. He is separated. Ethnic background/nationality' White English.
More about me...
Ronny received a letter from his GP in 2007 inviting him to be screened for prostate cancer as part of the ProtecT trial (Prostate Testing for Cancer and Treatment). He was aware of prostate cancer because his brother had already had it, and so Ronny went along. He was not expecting that he would have cancer, but thought he might be able to help others like his brother. The screening and further tests showed that he did in fact have prostate cancer.
Ronny agreed to be screened for a prostate cancer trial because he thought it might help his...
Ronny agreed to be screened for a prostate cancer trial because he thought it might help his...
Ronny was prepared to let the computer decide which treatment he would have for prostate cancer,...
Ronny was prepared to let the computer decide which treatment he would have for prostate cancer,...
Waiting to hear which group he was in was 'a long few minutes'. Ronny hoped he'd be in the active...
Waiting to hear which group he was in was 'a long few minutes'. Ronny hoped he'd be in the active...
FOOTNOTE: Randomised trials are done when we don’t know which treatment is best, in other words when the relative merits and disadvantages of different treatments are uncertain. It is important to realise that in about half of trials, the new treatment will turn out to be better, but in the other half it will turn out to be worse. This means that, going into a trial, everyone, regardless of which of the treatment groups the computer allocates them to, must have similar chances of a good outcome. If, in spite of the treatment uncertainties that the trial has been designed to address, people would strongly prefer one of the treatments being compared, they should not volunteer for the trial.
People are allocated at random to one of the groups in the trial, often by using a computer programme. Their personal characteristics are not taken into account when they are allocated to one or the other treatment. Random allocation helps ensure we are comparing two very similar groups of patients, so if one group does better than another, it is very likely to be because the treatments being compared have different effects, and not because of differences between the people in the groups. That's why random allocation to the treatment comparison groups is so important.